Breast cancer AI firm Volpara sees strong cash receipts

Breast cancer AI firm Volpara sees strong cash receipts
Rebecca Howard
ASX-listed Volpara Health Technologies collected its highest quarterly cash receipts since listing in 2016. Wellington-based Volpara, which focuses on early detection of breast cancer using artificial intelligence, said it received nearly $5.0 million in the first quarter to June 20, up 112 percent on the year.  It was the fourth straight quarter with cash receipts over $4.5 million. “Q1 saw the emergence of covid-19, but we’re very heartened by the strong cash receipts, negligible churn, and the fact that we got a significant number of n...

More Services

Creative solutions needed to keep NZ workers
Economy

Creative solutions needed to keep NZ workers

Robert Walters sees talent migration potentially getting worse in 2025.

‘Battle-hardened’ Trade Window eyes growth
Markets

‘Battle-hardened’ Trade Window eyes growth

The customs software minnow has weathered the storm. What next?

Pattrick Smellie 21 Nov 2024
Crimson big enough for ASX IPO: Beaton
Finance

Crimson big enough for ASX IPO: Beaton

A US market listing at a greater scale looks more likely.

Pattrick Smellie 06 Nov 2024
CoreLogic data suggests property market floor is nigh
Property

CoreLogic data suggests property market floor is nigh

Broad economic trends underpin the latest figures, CoreLogic's economist says.